Brainomix Launches Award-Winning Next Generation Stroke AI Platform with Novel Net Water Uptake Technology

Brainomix, a global leader in AI-powered imaging solutions for stroke and lung fibrosis, has unveiled its latest innovation, Brainomix 360 Stroke Next Generation, at the International Stroke Conference (ISC). This new platform has already garnered significant recognition, winning the prestigious Red Dot Design Award for excellence in usability and innovation. The award highlights Brainomix's commitment to creating intuitive and impactful tools that enhance clinical decision-making in stroke care.

A standout feature of the Brainomix 360 platform is its industry-first integration of net water uptake (NWU) technology. NWU provides a quantitative measure of water content in brain tissue affected by stroke, offering deeper insights into the extent and severity of stroke injury. This novel approach enables clinicians to better assess the progression of ischemic damage, which is critical for determining the most effective treatment strategies. By quantifying tissue water uptake, the platform supports more precise patient stratification and personalized therapeutic interventions.

The Brainomix 360 platform builds on the company’s established expertise in AI-driven imaging analysis, combining advanced algorithms with user-friendly design. Its enhanced usability ensures that healthcare professionals can quickly interpret complex imaging data, facilitating timely and accurate treatment decisions. The platform’s comprehensive stroke assessment capabilities include automated detection and quantification of ischemic lesions, hemorrhages, and perfusion abnormalities, all integrated within a streamlined workflow.

The introduction of NWU technology represents a significant advancement in stroke imaging. Traditional imaging methods often rely on visual assessment and indirect markers of tissue damage, which can be subjective and variable. Brainomix 360’s quantitative NWU metric provides an objective biomarker that correlates with tissue viability and potential for recovery. This can improve patient outcomes by guiding interventions such as thrombolysis or thrombectomy more effectively.

Brainomix’s launch of this next-generation platform at ISC underscores the growing role of artificial intelligence in transforming stroke care. With stroke being a leading cause of disability and death worldwide, innovations that enhance diagnostic accuracy and treatment personalization are urgently needed. Brainomix 360’s award-winning design and novel technological capabilities position it as a valuable tool in the global effort to improve stroke management and patient prognosis.

Looking forward, Brainomix aims to expand the application of its AI technologies beyond stroke to other neurological and pulmonary conditions. The success of Brainomix 360 demonstrates the potential of combining cutting-edge AI with clinical expertise to deliver impactful healthcare solutions. As adoption of such technologies increases, they are expected to play a pivotal role in advancing precision medicine and improving outcomes for patients with complex diseases.